PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Histamine H1 Receptor 1,170 Target Target Platelet Activating Factor 9,915 25 0.01 -0.99 0.02 0.65
Histamine H1 Receptor 1,170 Target Disease Migraine 24,200 2 0.00 -1.00 0.00 0.55
Histamine H1 Receptor 1,170 Target Disease Leishmaniasis 15,049 1 0.00 -1.00 0.00 0.54
Histamine H1 Receptor 1,170 Target Target Cox-2 21,583 2 0.00 -1.00 0.00 0.55
Histamine H1 Receptor 1,170 Target Disease Malaria 56,215 10 0.00 -1.00 0.01 0.57
Histamine H1 Receptor 1,170 Target Target Collagen 138,882 3 0.00 -1.00 0.00 0.51
Histamine H1 Receptor 1,170 Target Disease Rheumatoid Arthritis 78,952 2 0.00 -1.00 0.00 0.52
Histamine H1 Receptor 1,170 Target Disease Itching 5,798 11 0.00 -0.99 0.01 0.64
Histamine H1 Receptor 1,170 Target Disease Asthenia 3,478 1 0.00 -1.00 0.00 0.58
Histamine H1 Receptor 1,170 Target Disease Sarcoidosis 19,176 1 0.00 -1.00 0.00 0.54
Histamine H1 Receptor 1,170 Target Target Histamine H4 Receptor 168 10 0.02 -0.97 0.06 0.74
Histamine H1 Receptor 1,170 Target Disease Allergic Rhinitis 12,280 90 0.02 -0.96 0.08 0.70
Histamine H1 Receptor 1,170 Target Disease Epilepsy 71,172 2 0.00 -1.00 0.00 0.52
Histamine H1 Receptor 1,170 Target Target APOE 12,771 1 0.00 -1.00 0.00 0.55
Histamine H1 Receptor 1,170 Target Target CCL2 3,560 1 0.00 -1.00 0.00 0.58
Histamine H1 Receptor 1,170 Target Disease Headache 50,687 14 0.00 -0.99 0.01 0.58
Histamine H1 Receptor 1,170 Target Disease Mania 7,698 1 0.00 -1.00 0.00 0.56
Histamine H1 Receptor 1,170 Target Disease Psoriasis 26,882 3 0.00 -1.00 0.00 0.56
Histamine H1 Receptor 1,170 Target Disease Vertigo 10,084 2 0.00 -1.00 0.00 0.57
Histamine H1 Receptor 1,170 Target Disease Seizures 66,465 6 0.00 -1.00 0.01 0.55
Histamine H1 Receptor 1,170 Target Target CXCL2 750 1 0.00 -1.00 0.00 0.63
Histamine H1 Receptor 1,170 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.00 0.49
Histamine H1 Receptor 1,170 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.00 0.51
Histamine H1 Receptor 1,170 Target Drug Doxantrazole 122 4 0.01 -0.98 0.03 0.71
Histamine H1 Receptor 1,170 Target Disease Inflammation 252,734 65 0.00 -0.97 0.06 0.58
Histamine H1 Receptor 1,170 Target Target CXCL10 2,386 1 0.00 -1.00 0.00 0.59
Histamine H1 Receptor 1,170 Target Disease Angioedema 3,997 3 0.00 -1.00 0.00 0.61
Histamine H1 Receptor 1,170 Target Disease Ulcers 45,142 1 0.00 -1.00 0.00 0.51
Histamine H1 Receptor 1,170 Target Disease Lung Cancer 91,416 2 0.00 -1.00 0.00 0.51
Histamine H1 Receptor 1,170 Target Disease Pain 409,851 24 0.00 -0.99 0.02 0.54
Histamine H1 Receptor 1,170 Target Target BDNF 11,163 1 0.00 -1.00 0.00 0.55
Histamine H1 Receptor 1,170 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.00 0.53
Histamine H1 Receptor 1,170 Target Disease Sinusitis 12,330 1 0.00 -1.00 0.00 0.55
Histamine H1 Receptor 1,170 Target Disease Asthma 109,610 71 0.01 -0.97 0.06 0.61
Histamine H1 Receptor 1,170 Target Drug Doxepin 1,018 21 0.02 -0.98 0.02 0.74
Histamine H1 Receptor 1,170 Target Disease Sleep Disorders 6,847 2 0.00 -1.00 0.00 0.58
Histamine H1 Receptor 1,170 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.00 0.48
Histamine H1 Receptor 1,170 Target Disease Leukemia 162,805 7 0.00 -1.00 0.01 0.53
EPHA4 357 Target Target BDNF 11,163 1 0.00 -1.00 0.00 0.57
EPHA4 357 Target Disease Lung Cancer 91,416 2 0.00 -1.00 0.01 0.54
ApoE4 1,525 Target Target Antithrombin 13,773 1 0.00 -1.00 0.00 0.54
Trace Amine-Associated Receptor 1 64 Target Disease Dyslipidemia 15,225 1 0.00 -0.99 0.02 0.60
DAPK2 27 Target Target DAPK1 205 6 0.08 -0.87 0.22 0.81
DAPK2 27 Target Target ERK1 18,374 1 0.00 -0.98 0.04 0.61
DAPK2 27 Target Disease Multiple Myeloma 24,594 1 0.00 -0.98 0.04 0.60
DAPK2 27 Target Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
AP2M1 7 Target Disease Hepatitis 163,842 1 0.00 -0.93 0.14 0.58
AP2M1 7 Target Disease Infection 766,637 1 0.00 -0.93 0.14 0.55
Trace Amine-Associated Receptor 1 64 Target Disease Leukemia 162,805 1 0.00 -0.99 0.02 0.54
Trace Amine-Associated Receptor 1 64 Target Target EGF 27,487 1 0.00 -0.99 0.02 0.58
Trace Amine-Associated Receptor 1 64 Target Disease Attention Deficit Hyperactivity Disorder 14,687 3 0.00 -0.98 0.05 0.63
DAPK2 27 Target Target Collagen 138,882 1 0.00 -0.98 0.04 0.56
Trace Amine-Associated Receptor 1 64 Target Disease Dyskinesia 9,738 1 0.00 -0.99 0.02 0.61
Trace Amine-Associated Receptor 1 64 Target Target Catechol O-Methyltransferase 2,877 1 0.00 -0.99 0.02 0.64
Trace Amine-Associated Receptor 1 64 Target Disease Schizophrenia 77,034 7 0.00 -0.94 0.11 0.61
Trace Amine-Associated Receptor 1 64 Target Disease Hyperglycemia 28,168 1 0.00 -0.99 0.02 0.58
BMP-2B 18 Target Target Activin A 2,048 1 0.01 -0.97 0.06 0.67
BMP-2B 18 Target Target BMP-2 3,889 3 0.01 -0.91 0.17 0.68
BMP-2B 18 Target Target BMP-4 1,255 6 0.04 -0.81 0.33 0.74
BMP-2B 18 Target Target Collagen 138,882 6 0.00 -0.82 0.33 0.61
DAPK2 27 Target Disease Anemia 81,663 1 0.00 -0.98 0.04 0.57
DAPK2 27 Target Disease Leukemia 162,805 1 0.00 -0.98 0.04 0.56
BMP-2B 18 Target Target BMP-6 386 1 0.01 -0.97 0.06 0.72
FABP3 134 Target Disease Ventricular Dysfunction 12,856 1 0.00 -1.00 0.01 0.59
FABP3 134 Target Disease Cholesterol 182,390 6 0.00 -0.98 0.04 0.57
FABP3 134 Target Target FABP1 90 10 0.09 -0.91 0.11 0.84
FABP3 134 Target Target APOE 12,771 2 0.00 -0.99 0.01 0.61
FABP3 134 Target Disease Hypotension 42,123 1 0.00 -1.00 0.01 0.56
FABP3 134 Target Disease Niemann Pick Disease 1,234 1 0.00 -1.00 0.01 0.66
FABP3 134 Target Target APOA1 958 1 0.00 -1.00 0.01 0.66
FABP3 134 Target Disease Shock 134,031 2 0.00 -0.99 0.01 0.55
FABP3 134 Target Target BNP 6,842 2 0.00 -0.99 0.01 0.62
FABP3 134 Target Target Adiponectin 11,994 5 0.00 -0.98 0.04 0.63
DAPK2 27 Target Disease Breast Cancer 173,695 4 0.00 -0.92 0.15 0.59
FABP3 134 Target Disease Osteoporosis 46,215 2 0.00 -0.99 0.01 0.57
FABP3 134 Target Target ANGPTL4 289 2 0.01 -0.99 0.01 0.73
FABP3 134 Target Disease Schizophrenia 77,034 3 0.00 -0.99 0.02 0.57
FABP3 134 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.52
DAPK2 27 Target Disease Mesothelioma 11,198 1 0.00 -0.98 0.04 0.62
DAPK2 27 Target Disease Heart Disease 118,291 1 0.00 -0.98 0.04 0.56
DAPK2 27 Target Disease Inflammation 252,734 1 0.00 -0.98 0.04 0.55
DAPK2 27 Target Target CD34 24,598 1 0.00 -0.98 0.04 0.60
BMP-2B 18 Target Target BMP-7 1,112 2 0.01 -0.94 0.11 0.71
BMP-2B 18 Target Disease Basal Cell Carcinoma 7,953 1 0.00 -0.97 0.06 0.63
EPHA4 357 Target Target CD34 24,598 1 0.00 -1.00 0.00 0.55
DNAJB1 44 Target Disease Schizophrenia 77,034 1 0.00 -0.99 0.02 0.57
DNAJB1 44 Target Disease Inflammation 252,734 3 0.00 -0.97 0.07 0.56
DNAJB1 44 Target Target BDNF 11,163 1 0.00 -0.99 0.02 0.61
DNAJB1 44 Target Disease Leukemia 162,805 1 0.00 -0.99 0.02 0.55
DNAJB1 44 Target Target CXCL3 145 2 0.03 -0.97 0.05 0.77
DNAJB1 44 Target Target Cox-2 21,583 1 0.00 -0.99 0.02 0.59
DNAJB1 44 Target Target ERK2 3,287 1 0.00 -0.99 0.02 0.64
DNAJB1 44 Target Target CCL2 3,560 2 0.01 -0.98 0.05 0.66
DNAJB1 44 Target Disease Shock 134,031 18 0.01 -0.77 0.41 0.62
DNAJB1 44 Target Disease Infection 766,637 1 0.00 -0.99 0.02 0.52
Glutathione S-Transferase Theta-1 70 Target Disease Inflammatory Bowel Disease 24,375 1 0.00 -0.99 0.01 0.58
DNAJB1 44 Target Disease Diarrhea 51,986 1 0.00 -0.99 0.02 0.57
Ck-beta-11 4 Target Target Exodus-3 8 1 0.18 -0.81 0.25 0.89
Ck-beta-11 4 Target Target CD34 24,598 1 0.00 -0.87 0.25 0.63
Ck-beta-11 4 Target Disease Breast Cancer 173,695 1 0.00 -0.87 0.25 0.59